Monthly lists of letters for healthcare professionals on the safety of medicines
Letters sent to healthcare professionals in July 2011 to inform of new safety information and advice.
|Date issued||Product||Safety information|
|18 July 2011||Cardioxane (dexrazoxane)||Restricted use (30Kb)|
|28 July 2011||Thyrogen (thyrotropin alfa)||Update on supply and treatment recommendations (63Kb)|
|29 July 2011||Actos, Competact (pioglitazone)||Small increased risk of bladder cancer (77Kb)|
|29 July 2011||Multaq (dronedarone)||Information following preliminary study results showing increased cardiovascular risk (1057Kb)|